Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
Saved in:
| Title: | Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03). |
|---|---|
| Authors: | Kobayashi K; Department of Breast Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan. kokorok-medicaloncology@memoad.jp., Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan., Mizuno T; Department of Medical Oncology, Mie University Hospital, Tsu, Japan., Miura K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Tokuda Y; Breast Center, Seirei Yokohama Hospital, Yokohama, Japan., Yoshinami T; Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Suita, Japan., Kawaguchi H; Department of Breast Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan., Ohtani S; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Saeki T; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka, Japan., Toi M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University Hospital, Kyoto, Japan., Takeuchi M; Graduate School of Mathematical Sciences, The University of Tokyo, Tokyo, Japan., Ito Y; Department of Breast Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Oct; Vol. 201 (3), pp. 409-415. Date of Electronic Publication: 2023 Jul 22. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-023-07030-x |
